Vibetech

Executive Summary

Vibetech is a US-based digital health company developing and commercializing therapeutic vibration devices designed to improve strength, reduce pain, and accelerate recovery in patients with mobility impairments. Its FDA-listed technology delivers passive, non-electrical neuromuscular therapy, primarily targeting older adults and other at-risk populations in clinical and senior care settings. Founded in 2018 and headquartered in San Francisco, the company aims to enable faster recovery with less pain through accessible, reimbursable treatment solutions. While the company has not disclosed funding or valuation details, its focus on a large and growing demographic—aging populations with mobility issues—positions it in a sizable market. Vibetech's differentiation lies in its non-invasive, non-pharmacological approach, which may appeal to providers seeking to reduce opioid use and improve patient outcomes. However, adoption depends on building clinical evidence, securing reimbursement, and competing with established physical therapy and vibration platforms. The company's progress remains early-stage with limited public data, but its mission and market need are compelling.

Upcoming Catalysts (preview)

• Q3 2026FDA 510(k) clearance for expanded indications (e.g., chronic pain or post-surgical recovery)70% success
• Q4 2026Strategic partnership or pilot program with a major senior care operator (e.g., Brookdale, Sunrise)50% success
• Q2 2026Publication of peer-reviewed clinical study demonstrating efficacy in fall prevention or muscle strength60% success